Home Insights Identification of External Opportunities to Strengthen Client’s Portfolio in Emerging Markets

Identification of External Opportunities to Strengthen Client’s Portfolio in Emerging Markets

Less than 1 min read

A global pharmaceutical company approached SmartAnalyst to help improve its portfolio of external opportunities within emerging markets. SmartAnalyst took up the challenge to develop a list of attractive indications within the GI, Oncology, and Diabetes therapy areas.

SmartAnalyst utilized a two-phased approach to identify potential assets for each therapy area. Through identification and shortlisting of assets, SmartAnalyst was able to prioritize each asset based on pre-defined criteria and client strategic considerations.

Read the full case study here.